Amaryllis: Wholly-owned subsidiary Fukgin grain received drug clinical trial approval notification.

Announcement of Ronghua Pharmaceutical: The Fu Ganlin granules applied by its wholly-owned subsidiary, Guangzhou Ronghua Pharmaceutical Co., Ltd., have recently been granted a drug clinical trial approval notice by the National Medical Products Administration, allowing the product to conduct clinical trials for adult Asthenic cold.